AI assistant
Cigna Group — Director's Dealing 2019
Feb 6, 2019
29918_dirs_2019-02-05_e64e0c70-d65e-422b-ba26-09debb1b9ba5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2019-02-01
Reporting Person: Miller Steven B (EVP, Chief Clinical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-04 | Common Stock, $.01 Par Value | A | 4179.0000 | $0.0000 | Acquired | 20311.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-01 | Phantom Stock Units | $0.0000 | A | 154.6726 | Acquired | Common Stock, $.01 Par Value (154.6726) | Direct |
Footnotes
F1: Total holdings were increased by one share of common stock due to a rounding error on the Form 4 report that was filed on December 26, 2018.
F2: Phantom Stock Units credited under Express Scripts Executive Deferred Compensation Plan.
F3: Upon distribution, each Phantom Stock Unit converts to one share of Cigna Corporation Common Stock.
F4: Basic Company Credit by Cigna Corporation to Participant's account in the Express Scripts Executive Deferred Compensation Plan; the Basic Company Credit is fully vested once credited to the Participant's account.